Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T15:51:51.464Z.
Calculation as of: 2026-10-06T15:51:51.464Z.
Quote observation: 2026-10-06T15:50:08.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2eba736d2827de544c9f141b3fafa3dea8ffa5f0a614b8c2b2ac1915a5af89f6
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Century Therapeutics, Inc.
Market Cap
$250.79M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$258.32M
Price/FCF Ratio
459.64
TTM Avg
239.45
3Y Avg
256.85
5Y Avg
209.66
Market Cap
$252.60M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$245.27M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | $250.79M | N/A | N/A | N/A | N/A |
| Quantum-Si incorporated (QSI)vs › | $251.43M | N/A | N/A | N/A | N/A |
| AC Immune S.A. (ACIU)vs › | $257.49M | N/A | 5.28 | 5.50 | 5.50 |
| Anika Therapeutics, Inc. (ANIK)vs › | $258.32M | 459.64 | 239.45 | 256.85 | 209.66 |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $252.60M | N/A | N/A | N/A | N/A |
| Q32 Bio Inc. (QTTB)vs › | $248.68M | N/A | 8.17 | 8.17 | 8.17 |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $245.27M | N/A | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $244.52M | N/A | N/A | N/A | N/A |
| Palisade Bio, Inc. (PALI)vs › | $262.97M | N/A | N/A | N/A | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $244.33M | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
